David Arkowitz, Chief Financial Officer at Flexion Therapeutics Inc (FLXN), sold 2,248 shares at $10.06 ($23K) on 2019-05-08, disclosed to the SEC on 2019-05-09.
Scheduled sale ($23k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2023-10-31 | $5K | — | Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |